PRACTITIONER DISPENSARY PROGRAM TERMS AND CONDITIONS

PLEASE READ THIS AGREEMENT CAREFULLY. IT INCLUDES COMMISSION AND PAYMENT CONDITIONS, ACCOUNT SUSPENSION AND TERMINATION RIGHTS, CONFIDENTIALITY OBLIGATIONS, LIMITATIONS OF LIABILITY, AND BINDING INDIVIDUAL ARBITRATION.

1. Agreement; Relationship to Other Policies

These Practitioner Dispensary Program Terms and Conditions (“Agreement”) govern applications for and participation in the practitioner dispensary program operated by Formula IQ Holdings, LLC, a Georgia limited liability company (“Formula IQ,” “Company,” “we,” “us,” or “our”).

“Program” includes the practitioner application, practitioner accounts, public profiles, dispensary pages, recommendation tools, purchase links, commission features, and related services, regardless of the branding used for those features.

“Practitioner,” “you,” and “your” mean the individual or business applying for or participating in the Program. A person accepting for a business represents that they have authority to bind that business.

This Agreement supplements the Formula IQ website Terms & Conditions, Privacy Policy, applicable order and shipping policies, and any Program compensation schedule expressly presented to you. Those documents must be made available through the registration process.

For practitioner participation, account access, commissions, Program confidentiality, and disputes under this Agreement, this Agreement controls over conflicting general website language. The specific final-sale provisions in Section 6 control over inconsistent general return language incorporated from the website.

A separate written agreement signed by Formula IQ may modify identified provisions. Practitioners cannot modify these terms through their own purchase orders, website statements, or communications.

Patients are not parties to this Agreement merely because they receive a recommendation. Their purchases are governed by the terms presented to them through the Formula IQ purchasing process and applicable law.

2. Eligibility and Account Approval

Applicants must be at least 18 years old, have legal capacity to contract, and provide complete and accurate identity, professional, business, contact, and payment information.

The Program is available only to practitioners whose professional practice is located in the United States. Applicants must identify their country and provide an accurate U.S. practice location. A country selection is an eligibility attestation and does not replace Formula IQ's right to verify the information. An application with a missing or non-U.S. country is not eligible for approval or Program activation.

You must accurately identify your credentials and maintain all licenses, certifications, registrations, and authorizations required for the activities you perform. You may not represent yourself as a licensed professional or specialist unless that representation is accurate and legally permitted.

Formula IQ may request supporting documentation, verify information, restrict participation by profession or jurisdiction, and approve or decline any application in its discretion, subject to applicable law.

Submission of an application, acceptance of these terms, or an existing wholesale or affiliate account does not guarantee approval.

You must promptly report material changes affecting eligibility, including license suspension, revocation, disciplinary restrictions, business ownership changes, or loss of authority to operate the account.

Program approval does not certify professional competence, create a professional affiliation beyond Program participation, or constitute an endorsement of your services.

3. Account Administration and Public Profiles

Practitioners may submit and update their profile information, including their name, credentials, practice information, biography, photo, logo, website, and location.

Information identified as public in the application or account interface may appear on the practitioner profile, dispensary, or directory. Account email addresses and telephone numbers will not be displayed publicly by default unless you authorize publication or include them in public-facing content.

You are responsible for the accuracy, legality, and permitted use of submitted information and materials. Formula IQ may review, edit, reject, remove, or unpublish content that is inaccurate, misleading, unauthorized, inappropriate for the Program, or inconsistent with Company policies.

You must safeguard account credentials and promptly report suspected unauthorized access. Staff may access the Program only through methods authorized by Formula IQ. You remain responsible for staff activity conducted under your authority.

Accounts, dispensary privileges, and commission rights may not be sold, transferred, or assigned without Formula IQ’s written approval.

4. Professional Responsibilities and Financial Disclosures

You are responsible for your professional services, patient relationships, recommendations, and compliance with applicable laws, licensing requirements, and professional standards.

Recommendations must reflect appropriate professional judgment and remain within your lawful scope of practice. Participation does not authorize the practice of medicine, pharmacy, nutrition, or another regulated profession.

Formula IQ supplies products and ecommerce services. It does not establish a clinician-patient relationship through your participation or assume responsibility for your independent clinical decisions.

You must not make false, misleading, unsubstantiated, or unauthorized claims about Formula IQ products. You must not represent dietary supplements as FDA-approved drugs or claim that they diagnose, treat, cure, or prevent disease contrary to applicable law.

You must clearly disclose your financial relationship with Formula IQ when recommending products or sharing compensated links, as required by applicable advertising rules, professional standards, and other law.

You must not accept compensation prohibited by applicable professional, referral, fee-splitting, anti-kickback, or other requirements. You must notify Formula IQ when such a restriction applies so participation can be reviewed. Company approval does not establish that compensation is permissible for your profession or jurisdiction.

The activity benchmark in Section 10 does not require unnecessary purchases or recommendations. Patient interests and professional judgment must not be subordinated to earnings targets.

5. Recommendations, Purchase Links, and Subscriptions

The Program may allow you to select products, quantities, and available purchase options and send a patient a recommendation or purchase link.

A recommendation is not a completed purchase, payment authorization, or guarantee of availability. Patients remain free to decline, modify, or purchase recommendations, subject to available functionality.

Patients purchase directly from Formula IQ. Formula IQ is the seller of record and controls order acceptance, payment processing, product pricing, fulfillment, and customer service.

You may not collect payment credentials on Formula IQ’s behalf, place orders without proper authorization, enroll patients in recurring billing without their consent, or represent that a recommendation requires a patient to purchase.

Patients must review and authorize any subscription through the designated checkout process. You may not obscure recurring charges, billing frequency, or cancellation information.

Editing or resending a recommendation does not modify an order already placed or authorize a change to an existing subscription. Future subscription changes are governed by the applicable subscription terms and customer authorization.

6. Final Sales; No Returns; Order and Shipping Policies

ALL SALES THROUGH THE PROGRAM ARE FINAL. FORMULA IQ DOES NOT ACCEPT PRODUCT RETURNS.

Ingestible products are not eligible for discretionary refunds, whether opened or unopened. Personal response, taste, perceived effectiveness, a change of mind, or dissatisfaction does not create a right to a return, refund, or replacement.

Once an order is submitted, Formula IQ does not ordinarily accept customer-requested cancellations, modifications, or refunds. This applies to initial orders, processed subscription renewals, and preorders.

A preorder may be considered for a different item before shipment only when expressly permitted under the applicable published policy and approved by Formula IQ management. Any such accommodation is discretionary and does not establish a general exchange or refund right.

A confirmed manufacturing defect may qualify for an appropriate replacement after Formula IQ’s review. Formula IQ may require photographs, lot information, packaging information, or other reasonable evidence. A report of damage or dissatisfaction does not automatically establish a defect.

Shipping charges are nonrefundable except where required by law or expressly authorized by Formula IQ. Shipping estimates are not guaranteed delivery dates. Carrier-related damage, loss, delays, delivery disputes, and address issues are handled under the applicable shipping policy and law and do not automatically create a right to a refund.

Practitioners must direct patients with dispensary-order issues to Formula IQ customer service. Practitioners may not authorize returns, refunds, replacements, cancellations, delivery guarantees, or policy exceptions on Formula IQ’s behalf.

Products sent back without authorization do not create a refund entitlement. A discretionary accommodation by Formula IQ does not waive its policies or establish a precedent for another order.

Nothing in this Agreement excludes a remedy or other right that applicable law does not permit Formula IQ to exclude. Formula IQ may also cancel an order it cannot accept or fulfill and provide any refund required by law.

Cancellation of future subscription renewals is distinct from returning or canceling an order already processed. Patients retain applicable rights to discontinue future recurring purchases.

7. Commission Eligibility and Calculation

Eligible Practitioners may earn commissions under the compensation schedule communicated by Formula IQ and made available before compensated participation begins.

The schedule identifies applicable rates and material eligibility conditions. Rates may differ by account classification, product, or authorized promotion. No percentage or minimum income is promised by this Agreement.

Unless the applicable schedule states otherwise, commissions are calculated on eligible product revenue actually received after authorized discounts, excluding taxes, shipping, service charges, gift-card purchases, and amounts reversed or refunded.

A transaction must be genuine, paid, properly attributed, and approved under the Program. Pending dashboard amounts are estimates until validated.

Wholesale transactions, fabricated transactions, duplicate referrals, and purchases arranged principally to manufacture commissions are ineligible. Personal or practice purchases are commissionable only if expressly permitted by the applicable schedule.

Formula IQ may adjust commissions for payment reversals, chargebacks, fraud, order cancellations, authorized or legally required refunds, attribution errors, and other verified calculation errors. References to refunds in this section do not create a product return or refund policy.

Formula IQ will administer calculations in good faith and correct verified errors. Nothing permits arbitrary confiscation of valid commissions.

8. Ongoing Customer Attribution

The Program is intended to support ongoing attribution of qualifying customers to the referring Practitioner, including eligible repeat purchases and subscription renewals.

Ongoing or “lifetime” attribution applies only while participation remains active and eligible and subject to this Agreement and the applicable compensation schedule. It is not a promise of perpetual commissions or a vested right to income from purchases that have not yet occurred.

Attribution does not give a Practitioner ownership of a patient, exclusive access to a customer, or control over a customer’s purchasing choices.

Formula IQ may establish and apply reasonable attribution rules addressing previously assigned customers, competing referrals, customer requests, duplicate accounts, identification changes, fraud, and technical errors.

Customer choices and applicable privacy requirements will be respected. Formula IQ may correct attribution records but will not retroactively remove valid earned commissions solely to avoid payment.

You must report suspected attribution issues promptly and provide reasonable supporting information. No particular tracking technology or uninterrupted tracking performance is guaranteed.

9. Monthly Payouts and Minimum Balance

9.1 Payment date. Formula IQ schedules commission payouts on the 15th of each month. If that date falls on a weekend or banking holiday, processing may occur on the next business day. Payment-provider or bank processing may delay receipt after initiation.

9.2 Minimum payout. A minimum balance of $150 USD in approved, payable commissions is required for a regular payout. Pending, disputed, reversed, or unapproved amounts do not count toward the threshold.

9.3 Carryforward. Approved balances below $150 carry forward until the threshold is reached. They do not expire solely because the threshold has not been met, subject to applicable unclaimed-property requirements.

9.4 Payment requirements. You must provide accurate payment details, identity information, and reasonably required tax documentation. Payment may be delayed where information is missing, a payment fails, or a legal restriction prevents payment.

9.5 Review and adjustments. Formula IQ may temporarily hold amounts reasonably connected to a documented payment, fraud, attribution, or compliance review. Unrelated, undisputed payable amounts remain subject to the normal payment rules. Overpayments may be recovered through documented adjustments or repayment requests.

9.6 Statements. Please report suspected discrepancies within 60 days after the relevant statement becomes available. This administrative reporting period does not waive rights that cannot lawfully be waived.

9.7 Closure. Payment of a valid closing balance below $150 is addressed in Section 18.

10. Monthly Activity Benchmark

The Program is intended for actively participating practitioners.

Formula IQ uses $150 in monthly commission earnings as a general account-activity benchmark. This is separate from the $150 minimum payout balance.

The benchmark is not a required purchase amount, participation fee, guaranteed earnings level, or requirement to recommend medically unnecessary products.

Accounts that consistently fall below the benchmark may be reviewed. Formula IQ may consider the length of participation, seasonality, practice circumstances, overall engagement, wholesale relationship, compliance history, and other relevant factors.

Formula IQ may provide support, change account classification or privileges, deactivate an account, or discontinue participation in its discretion under Section 18. An isolated month below the benchmark does not automatically terminate an account.

Failure to meet the benchmark does not, by itself, forfeit valid commissions already earned. Meeting the benchmark does not guarantee continued participation.

11. Pricing, Discounts, and Promotions

Formula IQ determines retail prices, discount eligibility, promotional terms, and product availability.

Practitioners may communicate or use only authorized offers. Discounts may not be altered, combined, posted to coupon-distribution services, or used outside their authorized purpose.

A Practitioner may allocate compensation toward a patient discount only through a structure expressly approved by Formula IQ.

Prices and offers may change. A recommendation link does not reserve inventory, lock a price, or guarantee a promotional benefit. The applicable price and purchase terms are presented at checkout.

Formula IQ may correct pricing errors and decline or cancel affected orders, subject to applicable law.

12. Separate Wholesale Program

Dispensary participation and wholesale purchasing are separate arrangements.

Wholesale accounts remain subject to their applicable approval standards, purchasing requirements, resale restrictions, advertised-price policies, and other wholesale terms.

Wholesale prices are not patient dispensary prices. Practitioners may not use dispensary features to circumvent wholesale restrictions, expose restricted pricing, or collect unauthorized commissions on wholesale purchases.

Patient purchases made directly through Formula IQ are supported by Formula IQ. Purchases resold by a practitioner from their own inventory remain subject to the separate wholesale arrangement and the practitioner’s obligations as the reseller.

13. Patient Information and Privacy

You must have a lawful basis and any required permissions before entering another person’s information, sharing their information, or sending communications through the Program.

Use only information reasonably necessary for the authorized function. Do not place patient identifiers, diagnoses, medical records, laboratory results, treatment histories, or other sensitive information in public profiles, public links, or unauthorized fields.

You must not sell, scrape, disclose, export, or use Program information for an unrelated purpose. Patient communications must comply with applicable consent and messaging requirements.

A patient’s identity combined with a practitioner’s recommendation may itself constitute sensitive or protected information. Avoiding medical notes does not automatically remove privacy obligations.

This Agreement is not a HIPAA Business Associate Agreement and does not determine either party’s legal status. A workflow requiring a Business Associate Agreement or other safeguards must not be used until those requirements have been assessed and satisfied.

Formula IQ’s collection and use of information is subject to its Privacy Policy and applicable law. Neither party’s legal privacy duties are waived or transferred merely by accepting these terms.

You must promptly report suspected unauthorized access, improper disclosure, or a security incident involving the Program and reasonably cooperate with the response.

14. Confidentiality

“Confidential Information” includes nonpublic business information obtained through the Program, including restricted pricing, compensation arrangements, customer and practitioner information, vendor details, supplier relationships, marketing plans, technical systems, security information, and internal communications.

You may use Confidential Information only for authorized participation. You must protect it using reasonable safeguards and disclose it only to authorized personnel or professional advisers who require it and are subject to appropriate confidentiality duties.

These obligations apply during participation and for 24 months after participation ends. Trade secrets remain protected while they qualify as trade secrets, and personal information remains subject to applicable confidentiality and privacy requirements for as long as required.

Information is not confidential merely because it appears in the Program if it was lawfully known independently, independently developed, lawfully received without restriction, or becomes public without a breach.

Required legal disclosures are permitted, with advance notice where lawful and reasonable. Nothing prohibits reporting suspected unlawful conduct to authorities or making other legally protected disclosures.

15. Protection of Business Relationships

During participation and for 24 months afterward, you may not knowingly use Confidential Information or restricted Program access to:

a. Target Company customers, practitioners, or wholesale accounts learned about through the Program for diversion of business to a competing offering.

b. Circumvent Formula IQ in transactions with its suppliers, manufacturers, vendors, distributors, or business contacts introduced through the Program where doing so improperly deprives Formula IQ of an identifiable business opportunity or economic benefit.

c. Target Company employees or contractors identified through the Program for recruitment using confidential personnel information or inducement to breach their obligations.

These restrictions protect relationships with which you had material contact through the Program or about which you obtained Confidential Information. They do not impose general exclusivity or prohibit lawful competition, general advertising, independently established relationships, or ordinary care and recommendations to your own patients.

Nothing restricts a patient’s freedom to choose products, vendors, or practitioners.

16. Intellectual Property, Profile Content, and Marketing

Formula IQ retains ownership of its trademarks, website materials, software, dispensary systems, designs, documentation, and proprietary business records.

Approved Practitioners receive a limited, revocable, nonexclusive, nontransferable right to use Company-approved branding, product materials, and generated Program links solely for authorized participation. This permission expressly includes sharing authorized dispensary and recommendation links despite any general restriction on linking elsewhere in the website terms.

You may not modify Company marks, imitate Company websites, register confusingly similar domains or accounts, remove required disclosures, or imply Company endorsement beyond approved participation.

You retain ownership of original profile content you provide. You grant Formula IQ permission to host, display, format, and reproduce that content as reasonably necessary to operate your profile, recommendations, and Program participation. You represent that you have the necessary rights to submitted photographs, logos, and other materials.

Formula IQ may remove public profile content when participation ends while retaining records reasonably required for legal, security, transaction, or compliance purposes.

You may not copy protected software, reverse engineer the platform except where legally permitted, harvest restricted data, or use confidential Program materials to train third-party artificial intelligence systems.

17. Prohibited Conduct and Compliance Reviews

Prohibited conduct includes credential misrepresentation, account impersonation, fabricated purchases, attribution manipulation, unauthorized discount distribution, unlawful claims, deceptive advertising, unsolicited communications, unauthorized data access, and interference with the platform.

You may not use Formula IQ pages or systems to promote unauthorized competing offers, create misleading patient communications, or collect payment outside the approved purchasing process while representing the transaction as a Formula IQ order.

Formula IQ may review account activity, recommendations, public promotional materials, transactions, and information reasonably necessary to administer and protect the Program, subject to applicable privacy requirements.

You must reasonably cooperate with a compliance review. Formula IQ may require correction or removal of noncompliant content.

Nothing in this Agreement prohibits lawful reporting, truthful reviews, or other legally protected activity.

18. Suspension, Deactivation, and Termination

Formula IQ reserves the right, in its sole discretion and to the extent permitted by applicable law, to decline an application or suspend, restrict, deactivate, or terminate any practitioner account, dispensary, feature, commission eligibility, or Program participation at any time, with or without cause and with or without prior notice.

This right includes action based on inactivity, Program suitability, business changes, inaccurate information, loss of qualifications, abusive conduct, payment risk, security concerns, regulatory concerns, or a violation of applicable terms. These examples do not limit Formula IQ’s discretion.

Formula IQ is not required to provide a warning or opportunity to cure before taking action, except where applicable law requires otherwise. Providing assistance or an opportunity to correct a concern in one instance does not create that obligation in another.

You may end participation by submitting a written request to Formula IQ.

Upon termination:

a. Formula IQ may disable access, unpublish the dispensary, and deactivate recommendation links, discounts, and Program privileges.

b. Your authority to use Company branding and represent active participation ends.

c. No commissions accrue on purchases or subscription renewals occurring after termination, even if the customer was previously attributed to you, unless a separate written agreement or applicable law requires otherwise.

d. Valid commissions earned on eligible transactions before termination remain subject to validation, legitimate adjustments, and payment. Termination alone does not forfeit them.

e. Any remaining valid closing balance will be paid on the next practicable regular payout date after reasonable reconciliation and receipt of required payment information, even if below $150. Only amounts reasonably connected to unresolved issues may remain on hold.

f. Formula IQ may continue serving customers and fulfilling their authorized subscriptions. Practitioner termination does not itself cancel a patient’s orders or subscription.

g. You may not evade suspension or termination by creating a replacement account or acting through another person without written approval.

During a suspension, Formula IQ may pause access and withhold affected commissions pending review. If the review establishes that transactions remained eligible, valid commissions will be reconciled accordingly.

Confidentiality, the 24-month relationship restrictions, accrued payment obligations, privacy duties, intellectual property provisions, dispute provisions, and other terms intended to survive remain effective.

19. Program Changes

Formula IQ may change, suspend, replace, or discontinue Program functionality, eligibility classifications, products, or services.

Material changes to compensation, payout requirements, or this Agreement will be communicated before taking effect, except where immediate action is reasonably required for legal compliance, security, or fraud prevention.

Changes apply prospectively and do not retroactively eliminate valid commissions already earned. Future purchases and subscription renewals may be governed by prospectively updated rates.

Formula IQ may require renewed electronic acceptance. You may discontinue participation rather than accept revised terms.

20. Disclaimers and Limitation of Liability

The platform is provided on an “as is” and “as available” basis to the extent permitted by law. Formula IQ does not promise uninterrupted access, error-free tracking, particular earnings, patient participation, or continued availability of a feature or product.

Company educational content is not individualized medical advice. No particular health outcome is guaranteed.

To the extent legally permitted, Formula IQ disclaims implied warranties of merchantability, fitness for a particular purpose, and noninfringement concerning the Program technology.

Neither Formula IQ nor its personnel will be liable to a Practitioner for indirect, special, incidental, consequential, or punitive damages arising from Program participation, including anticipated profits or future commissions, to the extent those exclusions are lawful.

Subject to the exceptions below, Formula IQ’s aggregate liability under this Agreement will not exceed commissions paid or payable to the Practitioner during the 12 months preceding the event giving rise to the claim.

These limitations do not eliminate valid accrued payment obligations, excuse fraud or willful misconduct, or limit liability, warranties, or remedies that cannot lawfully be limited. This practitioner Agreement does not independently waive a patient’s product or consumer rights.

21. Indemnification

To the extent permitted by law, you will defend, indemnify, and hold harmless Formula IQ and its officers, employees, and agents against third-party claims and reasonable resulting losses and expenses attributable to your unauthorized product claims, unlawful professional conduct, credential misrepresentations, infringement through submitted content, misuse of personal information, or material breach of this Agreement.

This obligation applies only to the extent attributable to you or persons acting under your authority, and not to the extent caused by Formula IQ’s negligence, misconduct, or breach.

Formula IQ will provide reasonably prompt notice and reasonable cooperation. You may not settle a claim in a manner that admits wrongdoing by Formula IQ or imposes nonmonetary obligations on it without its written consent.

22. Independent Relationship; Taxes

Practitioners participate as independent professionals or businesses. No employment, agency, franchise, joint venture, or partnership is created.

You cannot bind Formula IQ, make commitments on its behalf, or represent that it supervises your professional practice.

You are responsible for your professional operations, licensing, insurance requirements, and taxes on compensation. Formula IQ may collect tax documentation, report payments, and make legally required withholding.

23. Governing Law and Dispute Resolution

23.1 Governing law. Georgia law governs this Agreement, excluding its conflict-of-law rules, except that the Federal Arbitration Act governs the arbitration agreement and mandatory applicable law remains controlling.

23.2 Informal resolution. Before initiating arbitration, the parties will provide written notice describing the dispute and requested resolution and attempt in good faith to resolve it for 45 days. Notices to Formula IQ must be sent to information@formulaiq.com. Formula IQ may send notices to the account email address. This process does not prevent urgent protective relief or require forfeiture of a claim while a deadline expires.

23.3 Arbitration. Subject to applicable law, unresolved disputes arising from this Agreement or Program participation will be decided by binding arbitration administered by the American Arbitration Association under its applicable Commercial Arbitration Rules, before one neutral arbitrator. The legal seat will be Atlanta, Georgia. Hearings may occur remotely by agreement or as permitted by the applicable rules.

The arbitrator may award remedies available under applicable law and this Agreement. Arbitration fees and recoverable legal expenses will be allocated under the applicable rules and law. Judgment on an award may be entered in a court with jurisdiction.

23.4 Individual proceedings. To the extent legally enforceable, disputes must proceed individually rather than as class, collective, or representative proceedings. Neither party is required to arbitrate a claim that applicable law prohibits from being arbitrated.

23.5 Court relief. Either party may seek temporary or preliminary relief to protect confidential information, intellectual property, personal information, or system security without waiving arbitration. Permitted court proceedings will be brought in a state or federal court with jurisdiction in Atlanta, Georgia, except where mandatory law or award enforcement requires otherwise.

23.6 Priority. This section replaces inconsistent arbitration-provider, venue, or dispute-resolution language in the general website terms for disputes between Formula IQ and a Practitioner concerning the Program. It does not amend a separate patient’s purchasing agreement.

BY ACCEPTING THIS AGREEMENT, YOU AGREE TO BINDING INDIVIDUAL ARBITRATION AND WAIVE A JURY TRIAL FOR CLAIMS SUBJECT TO ARBITRATION, TO THE EXTENT PERMITTED BY LAW.

24. General Provisions

Formula IQ is not responsible for performance delays caused by events outside its reasonable control, but this does not eliminate accrued payment obligations or mandatory legal duties.

Failure to enforce a provision does not waive later enforcement. A discretionary exception does not change the applicable policy.

If a provision is unenforceable, it will be limited or severed to the extent legally permitted without invalidating the remainder. A restrictive provision will not be expanded beyond what applicable law permits.

You may not assign this Agreement without written approval. Formula IQ may assign it in connection with a legitimate business reorganization or transfer, subject to applicable law and accrued obligations.

This Agreement and expressly incorporated documents constitute the agreement concerning Program participation. Amendments must be made through the process described here or a written agreement authorized by Formula IQ.

Electronic records and notices may be used for Program administration. Acceptance of this Agreement does not, by itself, constitute consent to unrelated marketing texts or other communications requiring separate consent.

25. Electronic Acceptance

By selecting the registration acceptance checkbox and submitting your application, you acknowledge that you have had an opportunity to read and retain this Agreement and the linked policies, understand the commission and payment conditions, and agree to be bound.

You confirm that your application information is accurate and that you have authority to accept for any business identified in the application.

Formula IQ may retain an electronic record identifying the accepting person or business, the accepted terms version, the acceptance date and time, and associated verification information.

Program contact: information@formulaiq.com